A Randomized, double-blind, active-controlled, international, multicenter study to evaluate the efficacy, safety, and tolerability of flexibly dosed esketamine nasal spray plus a new oral antidepressant compared to a placebo nasal spray plus a new standard of-care oral antidepressant in adult subjects with treatment-resistant depression